Amphetamine Sulfate

Narcolepsy, Attention Deficit Hyperactivity Disorder

Treatment

2 FDA approvals

20 Active Studies for Amphetamine Sulfate

What is Amphetamine Sulfate

Dextroamphetamine

The Generic name of this drug

Treatment Summary

Dextroamphetamine is a drug used to treat Attention Deficit Hyperactivity Disorder (ADHD). It was approved by the FDA in 2001 and works by balancing the neurotransmitters in the brain. Dextroamphetamine is the right-handed form of the drug amphetamine.

Dextrostat

is the brand name

image of different drug pills on a surface

Amphetamine Sulfate Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Dextrostat

Dextroamphetamine

1975

569

Approved as Treatment by the FDA

Dextroamphetamine, also known as Dextrostat, is approved by the FDA for 2 uses such as Narcolepsy and Attention Deficit Hyperactivity Disorder .

Narcolepsy

Helps manage Narcolepsy

Attention Deficit Hyperactivity Disorder

Used to treat Attention Deficit Hyperactivity Disorder (ADHD) in combination with Amphetamine

Effectiveness

How Amphetamine Sulfate Affects Patients

Dextroamphetamine is a drug that stimulates the central nervous system. It can increase blood pressure and act as a mild breathing aid. Exactly how dextroamphetamine works is not fully understood.

How Amphetamine Sulfate works in the body

We don't know exactly how amphetamines work, but they appear to help increase the amount of dopamine in the brain. This is done by blocking the reabsorption of dopamine, making more of it available to the brain, as well as stimulating the release of more dopamine. Additionally, amphetamines may affect the number of molecules responsible for transporting dopamine around the brain.

When to interrupt dosage

The measure of Amphetamine Sulfate is contingent upon the identified ailment. The quantity likewise fluctuates as per the technique of delivery (e.g. Tablet or Oral) featured in the table beneath.

Condition

Dosage

Administration

Narcolepsy

, 5.0 mg, 10.0 mg, 15.0 mg, 5.0 mg/mL, 2.5 mg, 7.5 mg, 20.0 mg, 30.0 mg, 3.125 mg, 6.25 mg, 9.375 mg, 12.5 mg, 1.875 mg, 1.25 mg, 3.75 mg, 25.0 mg, 18.75 mg, 60.0 mg, 40.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Liquid - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral

Attention Deficit Hyperactivity Disorder

, 5.0 mg, 10.0 mg, 15.0 mg, 5.0 mg/mL, 2.5 mg, 7.5 mg, 20.0 mg, 30.0 mg, 3.125 mg, 6.25 mg, 9.375 mg, 12.5 mg, 1.875 mg, 1.25 mg, 3.75 mg, 25.0 mg, 18.75 mg, 60.0 mg, 40.0 mg

, Oral, Capsule, extended release, Capsule, extended release - Oral, Liquid - Oral, Liquid, Tablet, Tablet - Oral, Solution, Solution - Oral, Capsule, Capsule - Oral

Warnings

Amphetamine Sulfate has nine contraindications and should not be utilized for the situations detailed in the table below.

Amphetamine Sulfate Contraindications

Condition

Risk Level

Notes

Hypertensive disease

Do Not Combine

Drug abuse

Do Not Combine

Pulse Frequency

Do Not Combine

Open-angle glaucoma

Do Not Combine

symptomatic cardiovascular disease

Do Not Combine

advanced arteriosclerosis

Do Not Combine

Hyperthyroidism

Do Not Combine

Agitation

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Dextroamphetamine may interact with Pulse Frequency

There are 20 known major drug interactions with Amphetamine Sulfate.

Common Amphetamine Sulfate Drug Interactions

Drug Name

Risk Level

Description

Clonidine

Major

The metabolism of Clonidine can be decreased when combined with Dextroamphetamine.

Dacomitinib

Major

The metabolism of Dacomitinib can be decreased when combined with Dextroamphetamine.

Enasidenib

Major

The metabolism of Enasidenib can be decreased when combined with Dextroamphetamine.

Erlotinib

Major

The metabolism of Erlotinib can be decreased when combined with Dextroamphetamine.

Flecainide

Major

The metabolism of Flecainide can be decreased when combined with Dextroamphetamine.

Amphetamine Sulfate Toxicity & Overdose Risk

Taking dextroamphetamine while pregnant can cause birth defects in mice, but this has not been studied in humans. It can also cause low birthweight, breathing and swallowing problems, and withdrawal symptoms in newborns. Women should not take dextroamphetamine while breastfeeding as it is passed to the baby through breast milk. It is not recommended for children under 3 years old as its long-term effects on children have not been determined.

Amphetamine Sulfate Novel Uses: Which Conditions Have a Clinical Trial Featuring Amphetamine Sulfate?

84 distinct investigations are presently assessing the potential of Amphetamine Sulfate in the treatment of Narcolepsy.

Condition

Clinical Trials

Trial Phases

Attention Deficit Hyperactivity Disorder

63 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 1, Phase 2

Narcolepsy

2 Actively Recruiting

Not Applicable, Phase 1

Amphetamine Sulfate Reviews: What are patients saying about Amphetamine Sulfate?

5

Patient Review

6/7/2019

Amphetamine Sulfate for Attention Deficit Disorder with Hyperactivity

50 years ago, I would've been written off as an underachiever. However, this treatment has allowed me to focus and get tasks done.

4.3

Patient Review

7/14/2015

Amphetamine Sulfate for Recurring Sleep Episodes During the Day

3

Patient Review

11/27/2020

Amphetamine Sulfate for Attention Deficit Disorder with Hyperactivity

I have found that I have difficulty urinating when on this medication. Has anyone else had this issue?

3

Patient Review

1/22/2020

Amphetamine Sulfate for Attention Deficit Disorder with Hyperactivity

I take this drug in addition to my Vyvanse when I start feeling down and anxious. It's been working well so far.

Patient Q&A Section about amphetamine sulfate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Dyanavel the same as Adderall?

"Both Adzenys ER and Adzenys XR-ODT are manufactured by Neos Therapeutics. Adzenys XR-ODT is a bioequivalent to Adderall XR. Dyanavel XR is a suspension form of extended-release amphetamine for ADHD."

Answered by AI

What ingredients are in amphetamine sulphate?

"Each tablet of amphetamine sulfate for oral administration contains 5 mg or 10 mg of the active ingredient. The tablet also contains the following inactive ingredients: crospovidone, silicified microcrystalline cellulose and stearic acid. The 10 mg tablet also contains FD&C Blue #1 aluminum lake ."

Answered by AI

What does amphetamine sulphate do?

"Amphetamine is a medication used to treat attention deficit hyperactivity disorder (ADHD). It act by altering the levels of some natural substances in the brain. Amphetamine is classified as a stimulant drug."

Answered by AI

What is the brand name for amphetamine sulfate?

"- The U.S. Food and Drug Administration (FDA) has approved Amphetamine sulfate (Evekeo, Adzenys XR ODT) to treat attention deficit hyperactivity disorder (ADHD).

The FDA has approved Amphetamine sulfate to treat ADHD."

Answered by AI

Clinical Trials for Amphetamine Sulfate

Image of Seattle Children's Hospital in Seattle, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Seattle, WA

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Seattle Children's Hospital

Image of St. Jude Children's Research Hospital in Memphis, United States.

Methylphenidate for Sickle Cell Disease

8 - 17
All Sexes
Memphis, TN

The purpose of this study is to determine if patients with sickle cell disease (SCD) can consistently take a drug called Methylphenidate (MPH) daily, once a day for 4 weeks to help with any thinking, attention or schoolwork problems and if they have any side effects. The study will assess any thinking or attention problems participants may have both before taking this drug and after. Additionally, the study will assess the decision-making process of the caregiver that may influence using this drug or not. Primary Objective: • Assess the feasibility, acceptability, and adherence to MPH treatment in children with SCD and EF deficits. Secondary Objective: • Evaluate neurobehavioral and safety outcomes following MPH treatment. Exploratory Objective: • Evaluate decision-making and determinants influencing methylphenidate utilization among parents.

Phase 1
Recruiting

St. Jude Children's Research Hospital

Andrew Heitzer, PhD

Have you considered Amphetamine Sulfate clinical trials?

We made a collection of clinical trials featuring Amphetamine Sulfate, we think they might fit your search criteria.
Go to Trials
Image of The University of Iowa in Iowa City, United States.

fMRI for Cognitive Flexibility

18 - 35
All Sexes
Iowa City, IA

The goal of this basic experimental research study is to examine how the human thalamus supports flexible thinking and behavior. Specifically, the research aims to elucidate how the mediodorsal (MD) thalamus encodes and updates "context"-the mental framework that determines which rules or actions are relevant in a given situation. This work may contribute to understanding why certain psychiatric conditions, such as schizophrenia and ADHD, involve difficulties with cognitive flexibility and control. The primary research questions are: Does the MD thalamus represent the context that organizes how working memory guides task selection? Does the MD thalamus signal when context needs to be updated after a change in task demands? Do these thalamic representations support generalization to new situations or rules? Participants will complete cognitive tasks while undergoing high-resolution brain imaging using 7-Tesla MRI. The investigators will combine behavioral data, computational modeling, and advanced neuroimaging analyses to examine how the thalamus interacts with the cortex during flexible decision-making.

Waitlist Available
Has No Placebo

The University of Iowa

Image of UCSF Nancy Friend Pritzker Psychiatry Building in San Francisco, United States.

Trigeminal Nerve Stimulation for ADHD in Children with Autism

7 - 14
All Sexes
San Francisco, CA

The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: * Does eTNS reduce ADHD symptoms? * Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: * 4-5 in-person visits * 4 brief virtual check-ins * Nightly use of the eTNS device with a small sticky patch applied to child's forehead * Randomized assignment (those who start with the sham device may try the active device later)

Recruiting
Device

UCSF Nancy Friend Pritzker Psychiatry Building

Image of The University of Texas at Austin in Austin, United States.

Transcranial Photobiomodulation for ADHD

18 - 44
All Sexes
Austin, TX

The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvements to cognition and emotion as well as brain oxygenation. This method is called transcranial photobiomodulation (tPBM). The investigators hypothesize that tPBM can improve cognition and brain oxygenation in adults with attention deficit hyperactivity disorder (ADHD). The investigators will investigate the effects of repeated tPBM sessions on cognitive functioning in adults with ADHD. Specifically, the investigators hypothesize that participants that receive tPBM will show improvements in response control, sustained attention, and working memory, as well as improvements in prefrontal hemodynamics and a reduction in ADHD symptoms.

Waitlist Available
Online Trial

The University of Texas at Austin

Have you considered Amphetamine Sulfate clinical trials?

We made a collection of clinical trials featuring Amphetamine Sulfate, we think they might fit your search criteria.
Go to Trials
Image of Louisiana State University in Baton Rouge, United States.

Virtual Reality for ADHD

18 - 25
All Sexes
Baton Rouge, LA

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Phase 4
Waitlist Available

Louisiana State University (+1 Sites)

Joshua M Langberg, PhD

Image of Duke University in Durham, United States.

Organizational Skills Training vs Mindfulness for ADHD

13 - 17
All Sexes
Durham, NC

This randomized control trial comparing Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) among adolescents with a pre-existing ADHD diagnosis presenting to the Duke ADHD Program. Both treatments are eight 90 minute sessions. The research component will involve a pre-treatment assessment and post-treatment assessment. Both assessments will involve adolescents and one caregiver to complete questionnaires over REDCap. Rating scales will include ADHD symptom severity (Conners 3: self and parent report), functional impairment (IRS: self and parent report), executive functioning (BRIEF-2: parent report), emotion dysregulation (DERS: self and parent report), trait mindfulness (FFMQ: self report), organizational skills (BRIEF-2: parent report), treatment satisfaction (self report and parent report) and credibility (self report and parent report). Post-treatment assessments for feasibility will include attendance (measured over the course of treatment) and homework completion rates on a scale of 1 to 5 in which 5 indicates higher homework completion. We will also assess acceptability via individual items on a Likert scale (self report): overall satisfaction, how much was learned about ADHD, usefulness of information learned, content relevance to individual experience, comprehension of strategies, confidence about using strategies, likelihood of using strategies, helpfulness to share with the group, benefits from hearing from other group members, willingness to recommend the same treatment to others, and whether or not treatment was beneficial.

Recruiting
Has No Placebo

Duke University

John Mitchell, PhD

Image of Kennedy Krieger Institute in Baltimore, United States.

Iron Supplementation for ADHD and Restless Sleep

8 - 18
All Sexes
Baltimore, MD

The goal of this clinical trial is to learn if iron supplementation works to restless sleep in youth with ADHD. A second goal is to learn if iron supplementation helps to ease ADHD symptoms. The main questions that this trial aims to answer are: Does 3 months of iron supplementation treatment improve parent- and youth self-reported sleep difficulties more than placebo? Does 3 months of iron supplementation treatment improve sleep as measured by actigraphy more than placebo? Does 3 months of iron supplementation treatment improve parent-reported and/or objectively measured attention more than placebo? Researchers will compare over-the-counter iron supplementation treatment to a placebo (a look-alike substance that contains no drug) to see if iron supplementation works to treat sleep difficulties in youth with ADHD. Participants will: * Take iron supplements every day for 3 months * Visit the clinic once before treatment begins and once at the end of treatment to complete tests and rating scales related to sleep and attention * Wear motion-monitoring leg bands while sleeping for one 2-week period before treatment begins and one 2-week period at the end of treatment

Phase 1 & 2
Waitlist Available

Kennedy Krieger Institute

Alison E Pritchard, PhD

Image of Montana State University in Bozeman, United States.

Speech-Gesture Combinations for Autism

Any Age
All Sexes
Bozeman, MT

This research study investigates how hand gestures can support language comprehension and communication skills of hearing speaking, non-speaking, and/or minimally verbal individuals with Autism Spectrum Disorders (ASD), who are especially disadvantaged by the lack of accessible services in their rural communities. Individuals with other cognitive profiles, including Developmental Language Disorder (DLD), ADHD, Dyslexia, and others are welcome too. The study uses methods of eye tracking and recording of brain activity to understand how hand gestures adapted from signs from American Sign Language, such as \[cry\], can promote successful understanding of words like "cry". The overarching goal is to help families effectively utilize gestures to support communication with their children.

Recruiting
Has No Placebo

Montana State University

Have you considered Amphetamine Sulfate clinical trials?

We made a collection of clinical trials featuring Amphetamine Sulfate, we think they might fit your search criteria.
Go to Trials